Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arcellx Inc (ACLX)

Arcellx Inc (ACLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stocks Under Pressure from Higher Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is down -0.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.12%. Stocks today are slightly...

APO : 178.61 (+2.23%)
BABA : 88.98 (-0.95%)
NVDA : 139.31 (+3.14%)
IPG : 30.10 (-0.92%)
OMC : 92.10 (-0.39%)
$SPX : 6,084.19 (+0.82%)
BIOA : 4.80 (+7.38%)
SMCI : 38.29 (-5.55%)
BIDU : 89.37 (+0.18%)
FTV : 78.28 (-0.05%)
$IUXX : 21,763.98 (+1.85%)
WDAY : 272.36 (+0.55%)
Insider Sale: Director at $ACLX (ACLX) Sells 300 Shares

Kavita Patel, a director at $ACLX ($ACLX), sold 300 shares of the company on 12-03-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares....

ACLX : 86.98 (+5.73%)
Global Cancer Rates Surge as Biotech Innovators Work on New Therapies

/CNW/ -- USA News Group – Cancer rates are rising globally, and the outlook is particularly concerning for men. A recent global study projects an 84% increase...

ONCY : 0.8537 (-0.62%)
ACLX : 86.98 (+5.73%)
ONC.TO : 1.22 (-0.81%)
GTHX : 7.15 (unch)
HALO : 47.39 (-3.40%)
SNY : 47.99 (-0.19%)
2 Potential Stocks to Buy From Barchart’s ‘Death Cross’ Indicator

While a security’s short-term moving average dipping below its long-term average warrants caution, this dynamic may also be a contrarian indicator.

IRTC : 89.93 (+3.49%)
ACLX : 86.98 (+5.73%)
Chart of the Day: Arcellx - Reimagining Cell Therapy

The Chart of the Day belongs to the immunotherapy company Arcellx (ACLX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest...

ACLX : 86.98 (+5.73%)
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results

/PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for...

ACLX : 86.98 (+5.73%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 86.98 (+5.73%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 86.98 (+5.73%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 86.98 (+5.73%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Arcellx, Inc. ("Arcellx" or the "Company") (NASDAQ: ACLX). Such investors are...

ACLX : 86.98 (+5.73%)

Barchart Exclusives

These 2 Dividend Stocks Were Stars in November. Is It Too Late to Buy?
These high-yield dividend stocks have posted great returns in 2024 and could keep heating up in the new year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar